Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients With Cardiogenic Shock From Acute Myocardial Infarction

NCT05168462 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

776

Enrollment

OTHER

Sponsor class

Conditions

Cardiogenic Shock
Myocardial Infarction

Interventions

DRUG: Reduced noradrenaline use

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)